Broker's call: Alembic Pharma (Buy)
JM Financial07-08-2023
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Newspaper Publication
We enclosed herewith Newspaper cuttings of Extracts of Unaudited Financial Results for the quarter ended 30th June, 2023, published in Economic Times & Indian Express (English Edition) and Financial Express (Gujarati Edition) on 5th August, 2023.05-08-2023
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
With reference to the captioned subject, please find enclosed herewith the intimation dated 5th August, 2023 received from Link Intime India Private Limited, Registrar and Share Transfer Agent regarding receipt of the request of the request(s)/application(s) from the registered shareholder(s) of the Company for issue of Duplicate Share Certificate(s).05-08-2023
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Please find attached the Voting Results and Scrutinizers Report.04-08-2023
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Please find attached herewith the Voting Results and Scrutinizers Report04-08-2023
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find enclosed herewith the intimation received dated 4th August, 2023 received from Link Intime India Private Limited, Registrar and Share Transfer Agent, regarding receipt of the request(s)/application(s) from the registered shareholder(s) of the Company for issue of Duplicate Share Certificate(s).04-08-2023
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Please find attached the proceedings of the meeting.04-08-2023
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Proceedings Of The 13Th Annual General Meeting Held On 4Th August, 2023
Proceedings of the Annual General Meeting Attached04-08-2023
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
With reference to the captioned subject, this is to inform the exchange that the audio recording has been hosted on the website of the Company04-08-2023
Q1FY24 Quarterly Result Announced for Alembic Pharmaceuticals Ltd.
Alembic Pharmaceuticals announced Q1FY24 results: Net Sales grew 18% to Rs 1,486 crore for Q1FY24. Net Profit for Q1FY24 at Rs 121 crore. Pranav Amin, Managing Director, Alembic Pharmaceuticals said, “The company grew in all the business segments with India outperforming the market with 9% growth, Ex-US generics grew 46%, API grew 31% and the US generics business grew 6%. We have also started commercializing products from our Oncology and Injectable facilities” Result PDF04-08-2023